![]() |
|
|
Vol. 57, Issue 4, 659-666, April 2000
1B- and
1D-Adrenoceptors by
Agonists and Inverse Agonists
The Department of Pharmacology (S.E.E., D.F.M., J.R.O., M.T.P.) and
the Vascular Biology Research Group (S.E.E., D.F.M., J.R.O., M.T.P.,
G.R.P., B.A.W.), The University of Kentucky College of Medicine, The
Division of Pharmaceutical Sciences (G.R.P., B.A.W.), The University of
Kentucky College of Pharmacy, Lexington, Kentucky; and The Department
of Molecular Cardiology, Lerner Research Institute, The Cleveland
Clinic Foundation, Cleveland, Ohio (D.M.P., D.J.J.W.)
The regulation of the cellular distribution and intracellular signaling
properties of the
1B- and
1D-
adrenoceptor (
1-AR) subtypes was examined in stably
transfected Rat 1 fibroblasts. In unstimulated cells,
1B-AR expression was noted primarily on the cell
surface. Treatment with phenylephrine induced internalization of the
1B-AR and promoted association with arrestin 2. The
internalized
1B-AR colocalized with the transferrin
receptor, an endosomal marker. In unstimulated fibroblasts, the
1D-AR was detected in a perinuclear orientation and was
colocalized with arrestin 2 in a compartment also containing the
transferrin receptor. After treatment with prazosin, which exhibits
inverse agonist properties, the
1D-AR was redistributed
from intracellular sites to the cellular periphery and was no longer
associated with the transferrin receptor or arrestin 2.
1D-AR-expressing cells exhibited a high degree of basal
activity for both inositol phosphate formation and extracellular signal
regulated kinase (ERK), which was reduced by treatment with prazosin.
In these cells, phenylephrine induced a dose-dependent increase in
inositol phosphate formation but had no effect on ERK activity. In
1B -AR-expressing cells, phenylephrine stimulated both
inositol phosphate formation and ERK activity. These data show that: 1)
there are differences in the cellular localization of the
1-AR subtypes; 2) the
1B-AR exhibits
expected G protein-coupled receptor activity regarding cellular
localization, agonist-mediated internalization, and coupling to second
messengers; and 3) the
1D-AR is constitutively active
and, as a result, is localized to intracellular compartments involved
in receptor recycling.
This article has been cited by other articles:
![]() |
M. C. Vinci, L. Bellik, S. Filippi, F. Ledda, and A. Parenti Trophic effects induced by {alpha}1D-adrenoceptors on endothelial cells are potentiated by hypoxia Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2140 - H2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Walwyn, C. J. Evans, and T. G. Hales {beta}-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of {micro} Opioid Receptors in Dorsal Root Ganglion Neurons J. Neurosci., May 9, 2007; 27(19): 5092 - 5104. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, N. Xu, T. Zhang, H. Zhang, Z. Li, F. Yin, Z. Lu, Q. Han, and Y. Zhang Mammalian Tolloid Alters Subcellular Localization, Internalization, and Signaling of {alpha}1a-Adrenergic Receptors Mol. Pharmacol., August 1, 2006; 70(2): 532 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Marti, R. Miquel, K. Ziani, R. Gisbert, M. D. Ivorra, E. Anselmi, L. Moreno, V. Villagrasa, D. Barettino, and P. D'Ocon Correlation between mRNA levels and functional role of {alpha}1-adrenoceptor subtypes in arteries: evidence of {alpha}1L as a functional isoform of the {alpha}1A-adrenoceptor Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1923 - H1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Paasche, T. Attramadal, K. Kristiansen, M. P. Oksvold, H. K. Johansen, H. S. Huitfeldt, S. G. Dahl, and H. Attramadal Subtype-Specific Sorting of the ETA Endothelin Receptor by a Novel Endocytic Recycling Signal for G Protein-Coupled Receptors Mol. Pharmacol., May 1, 2005; 67(5): 1581 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, C. G. Radu, L. V. Yang, L. A. Bentolila, M. Riedinger, and O. N. Witte Lysophosphatidylcholine-induced Surface Redistribution Regulates Signaling of the Murine G Protein-coupled Receptor G2A Mol. Biol. Cell, May 1, 2005; 16(5): 2234 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Uberti, C. Hague, H. Oller, K. P. Minneman, and R. A. Hall Heterodimerization with {beta}2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of {alpha}1D-Adrenergic Receptors J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Morris, R. R. Price, M. P. Smith, B. Lei, and D. A. Schwinn Cellular Trafficking of Human {alpha}1a-Adrenergic Receptors Is Continuous and Primarily Agonist-Independent Mol. Pharmacol., October 1, 2004; 66(4): 843 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hague, M. A. Uberti, Z. Chen, C. F. Bush, S. V. Jones, K. J. Ressler, R. A. Hall, and K. P. Minneman Olfactory receptor surface expression is driven by association with the {beta}2-adrenergic receptor PNAS, September 14, 2004; 101(37): 13672 - 13676. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hague, Z. Chen, A. S. Pupo, N. A. Schulte, M. L. Toews, and K. P. Minneman The N Terminus of the Human {alpha}1D-Adrenergic Receptor Prevents Cell Surface Expression J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 388 - 397. [Abstract] [Full Text] |
||||
![]() |
T. Kenakin Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Uberti, R. A. Hall, and K. P. Minneman Subtype-Specific Dimerization of {alpha}1-Adrenoceptors: Effects on Receptor Expression and Pharmacological Properties Mol. Pharmacol., December 1, 2003; 64(6): 1379 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gisbert, F. Perez-Vizcaino, A. L. Cogolludo, M. A. Noguera, M. D. Ivorra, J. Tamargo, and P. D'Ocon Cytosolic Ca2+ and Phosphoinositide Hydrolysis Linked to Constitutively Active {alpha}1D-Adrenoceptors in Vascular Smooth Muscle J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1006 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chalothorn, D. F. McCune, S. E. Edelmann, K. Tobita, B. B. Keller, R. D. Lasley, D. M. Perez, A. Tanoue, G. Tsujimoto, G. R. Post, et al. Differential Cardiovascular Regulatory Activities of the {alpha}1B- and {alpha}1D-Adrenoceptor Subtypes J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1045 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Hupfeld, S. Dalle, and J. M. Olefsky beta -Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Galpha s signaling in 3T3-L1 adipocytes PNAS, January 7, 2003; 100(1): 161 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chalothorn, D. F. McCune, S. E. Edelmann, M. L. Garcia-Cazarin, G. Tsujimoto, and M. T. Piascik Differences in the Cellular Localization and Agonist-Mediated Internalization Properties of the alpha 1-Adrenoceptor Subtypes Mol. Pharmacol., May 1, 2002; 61(5): 1008 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miserey-Lenkei, C. Parnot, S. Bardin, P. Corvol, and E. Clauser Constitutive Internalization of Constitutively Active Angiotensin II AT1A Receptor Mutants Is Blocked by Inverse Agonists J. Biol. Chem., February 15, 2002; 277(8): 5891 - 5901. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Waldrop, D. Mastalerz, M. T. Piascik, and G. R. Post alpha 1B- and alpha 1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 83 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Piascik and D. M. Perez alpha 1-Adrenergic Receptors: New Insights and Directions J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 403 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. KENAKIN Inverse, protean, and ligand-selective agonism: matters of receptor conformation FASEB J, March 1, 2001; 15(3): 598 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Ferrari and A. Bisello Cellular Distribution of Constitutively Active Mutant Parathyroid Hormone (PTH)/PTH-Related Protein Receptors and Regulation of Cyclic Adenosine 3',5'-Monophosphate Signaling by {beta}-Arrestin2 Mol. Endocrinol., January 1, 2001; 15(1): 149 - 163. [Abstract] [Full Text] |
||||
![]() |
R. Gisbert, M. A. Noguera, M. D. Ivorra, and P. D'Ocon Functional Evidence of a Constitutively Active Population of alpha 1D-Adrenoceptors in Rat Aorta J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 810 - 817. [Abstract] [Full Text] |
||||
![]() |
K. Ziani, R. Gisbert, M. A. Noguera, M. D. Ivorra, and P. D'Ocon Modulatory role of a constitutively active population of alpha 1D-adrenoceptors in conductance arteries Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H475 - H481. [Abstract] [Full Text] [PDF] |
||||